Catyalyst Pharmaceutical (CPRX) Posts Q3 Loss of 6c/Share
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.45 -0.16%
Revenue Growth %: +6.2%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Revenue Growth %: +6.2%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Catyalyst Pharmaceutical (NASDAQ: CPRX) reported Q3 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Catyalyst Pharmaceutical (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- Doximity downgraded by BofA on AI investment concerns, margin pressure
- KeyBanc Reiterates Overweight Rating on Worthington Steel Inc (WS)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
